摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,7-dibromo-2,3-bis(2-ethylhexyl)thieno[3,4-b]pyrazine | 1203451-24-4

中文名称
——
中文别名
——
英文名称
5,7-dibromo-2,3-bis(2-ethylhexyl)thieno[3,4-b]pyrazine
英文别名
——
5,7-dibromo-2,3-bis(2-ethylhexyl)thieno[3,4-b]pyrazine化学式
CAS
1203451-24-4
化学式
C22H34Br2N2S
mdl
——
分子量
518.399
InChiKey
DPZWTBJNYUXFLD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.73
  • 重原子数:
    27.0
  • 可旋转键数:
    12.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.73
  • 拓扑面积:
    25.78
  • 氢给体数:
    0.0
  • 氢受体数:
    3.0

反应信息

  • 作为反应物:
    描述:
    5,7-dibromo-2,3-bis(2-ethylhexyl)thieno[3,4-b]pyrazine 在 (1,1′-(1,8-naphthyridine-2,7-diyl) bis(N-(2,6-disopropylphenyl)ethan-1-imine))Ni2Br2 作用下, 以 四氢呋喃 为溶剂, 反应 1.0h, 生成 2,3-bis(2-ethylhexyl)thienopyrazine
    参考文献:
    名称:
    具有氧化还原活性配体的双核配合物促进共轭聚合物合成的链增长机制
    摘要:
    证明了具有氧化还原活性配体的双核镍配合物作为引发剂用于供体和受体共轭单体的链增长聚合的效用。机理分析表明,多个金属中心与氧化还原活性配体的偶联允许获得新的自由基途径,从而扩展了共轭聚合物合成的已知方法。
    DOI:
    10.1002/anie.202206044
  • 作为产物:
    参考文献:
    名称:
    具有氧化还原活性配体的双核配合物促进共轭聚合物合成的链增长机制
    摘要:
    证明了具有氧化还原活性配体的双核镍配合物作为引发剂用于供体和受体共轭单体的链增长聚合的效用。机理分析表明,多个金属中心与氧化还原活性配体的偶联允许获得新的自由基途径,从而扩展了共轭聚合物合成的已知方法。
    DOI:
    10.1002/anie.202206044
点击查看最新优质反应信息

文献信息

  • Photocontrolled Synthesis of n‐Type Conjugated Polymers
    作者:Eliot F. Woods、Alexandra J. Berl、Julia A. Kalow
    DOI:10.1002/anie.201915819
    日期:2020.4.6
    synthesize π-conjugated polymers (CPs) are dominated by thermally driven, transition-metal-mediated reactions. Herein we show that electron-deficient Grignard monomers readily polymerize under visible-light irradiation at room temperature in the absence of a catalyst. The product distribution can be tuned by the wavelength of irradiation based on the absorption of the polymer. Conversion studies are
    目前合成π-共轭聚合物(CP)的方法主要由热驱动的过渡属介导的反应控制。在本文中,我们表明缺乏电子的格氏单体在室温下在不存在催化剂的情况下在可见光辐射下容易聚合。可以基于聚合物的吸收通过照射的波长来调节产物分布。转化研究与不受控制的链增长过程一致;相应地,扩链产生全共轭的n型嵌段共聚物。初步结果表明,可以将聚合反应扩展为供体-受体交替共聚物。我们预计,该方法可以用作访问n型CP的新体系结构的平台,而无需过渡属催化。
  • Synthesis and Characterization of Bridged Bithiophene-Based Conjugated Polymers for Photovoltaic Applications: Acceptor Strength and Ternary Blends
    作者:Chiu-Hsiang Chen、Chao-Hsiang Hsieh、Martin Dubosc、Yen-Ju Cheng、Chain-Shu Hsu
    DOI:10.1021/ma902206u
    日期:2010.1.26
    Six of three-component donor-acceptor random copolymers P1-P6, symbolized as (thiophene donor)(m)-(thiophene acceptor)(n), were rationally designed and successfully synthesized by the palladium-catalyzed Stille Coupling, The 4H-cyclopenta[2, 1-b:3,4-b']dithiophene (CPDT) unit serves as the donor for P1-P4, while file benzothiadiazole (BT), quinoxaline (QU), dithienoquinoxaline, and thienopyrazine (TP) units are used as the acceptor for P1, P2, P3, and P4, respectively. P5 and P6 are structurally analogous to P1 and P2 except for using the dithieno[3.2-b:2',3'-d]silole (DTS) unit as the donor. Because the band gap lowering ability of the acceptor units in the polymer is in the order TP > BR > QU presumably due to the quinoid form Population in the polymers, the optical band gaps call be well adjusted to be 1.2, 1.6, and 1.8 eV for P4, P1, and P2, respectively. It is found that file two bridged bithiophene units, CPDT and DTS, have similar steric and electronic effects oil the P1 and P5 as well as P2 and P6, respectively, leading to comparable intrinsic properties and device performances. Bulk heterojunction photovoltaic cells based oil ITO/PEDOT:PSS/polymer:PC71BM/Ca/Al configuration were fabricated and characterized. Although P4 exhibits the lowest optical band gap, broadest absorption spectrum, and highest mobility, the too low-lying LUMO level hinders the efficient exciton dissociation, resulting in a low PCE of 0.7%. Compared with poly[2,6-(4,4-bis(2-ethylhexyl)-4H-cyclopenta[2,1-b;3,4-b']dithiophene)-alt-4,7-(2,1,3-benzothiadiazole)] (PCPDTBT), random copolymer P1 shows more blue-shifted, broader absorption spectrum, comparable mobility, and a higher PCE of 2.0%. In view of the fact that P1 shows it higher band gap with strong absorption in visible region, while PCPDTBT-has a lower band gap to mainly absorb NIR light, a BHJ device with the active layer containing ternary blend of PCPDTBT/P-1/PC71BM was investigated and achieved an enhanced PCE of 2.5%, which outperforms the devices based on the binary blending systems of PCPDTBT/PC7, BM (PCE = 1.4%) or P1/PC71 BM (PCE = 2.0%,,) Linder the identical conditions. Such an improvement is ascribed to file complementary absorption and compatible structure of P1 and PCPDTBT polymers.
查看更多

同类化合物

噻唑并[5,4-d]嘧啶-7(4H)-酮 噻唑并[5,4-d]嘧啶-5,7(4H,6H)-二酮 噻唑并[5,4-d]嘧啶-2(1H)-酮 噻唑并[5,4-d]嘧啶,5-氯- 噻唑[5,4-D]嘧啶-2-胺 叔丁基-(7-氯噻唑并[5,4-d]嘧啶-2-基)-胺 [1,3]噻唑并[5,4-D]嘧啶-7-胺 N7-丁基-n2-苯基噻唑并[5,4-d]嘧啶-2,7-二胺 N7-(4-甲氧基苯基)-n2-苯基噻唑并[5,4-d]嘧啶-2,7-二胺 N7-(3-氯苯基)-n2-苯基噻唑并[5,4-d]嘧啶-2,7-二胺 N2-苯基-n7-(3,4,5-三甲氧基苄基)噻唑并[5,4-d]嘧啶-2,7-二胺 N2,N7-二苯基-噻唑并[5,4-d]嘧啶-2,7-二胺 N-(7-氯-2-甲基噻唑并[5,4-D]嘧啶-5-基)新戊酰胺 8-苯胺基-9-硫杂-2,4,7-三氮杂双环[4.3.0]壬-2,7,10-三烯-5-硫酮 7-氯噻唑并[5,4-D]嘧啶 7-氯-N-(邻甲苯基)噻唑并[5,4-D]嘧啶-2-胺 7-氯-5-甲基-[1,3]噻唑并[5,4-d]嘧啶 7-氯-5-(三氟甲基)[1,3]噻唑并[5,4-d]嘧啶 7-氨基-噻唑并[5,4-d]嘧啶-2(1H)-硫酮 7-(甲硫基)噻唑并[5,4-D]嘧啶-2-羧酸甲酯 5-甲硫基-9-硫杂-2,4,7-三氮杂双环[4.3.0]壬-2,4,7,10-四烯 5,7-二氯噻唑并[5,4-D]嘧啶 5,7-二氯-2-甲基-噻唑并[5,4-d]嘧啶 4-(5-氯噻唑并[5,4-D]嘧啶-7-基)吗啉 2-苯胺基[1,3]噻唑并[5,4-d]嘧啶-7-醇 2-苯基噻唑并[5,4-d]嘧啶-7-胺 2-甲基-4H-噻唑并[5,4-d]嘧啶-5,7-二酮 2-乙氧基[1,3]噻唑并[4,5-d]嘧啶-5,7(4H,6H)-二酮 2-(甲基硫代)-噻唑并[5,4-d]嘧啶-7(4H)-酮 2,7-二氯噻唑并[5,4-D]嘧啶 2,5-二氯噻唑并[5,4-d]嘧啶 2,5-二氨基-6H-[1,3]噻唑并[4,5-e]嘧啶-7-酮 1-(7-氯噻唑并[5,4-d]嘧啶-2-基)-1,3-二甲基硫脲 1,3-二苄基-1-(7-氯噻唑并[5,4-d]嘧啶-2-基)硫脲 (7-氯噻唑并[5,4-d]嘧啶-2-基)苯胺 (7-氯噻唑并[5,4-d]嘧啶-2-基)异丙胺 (7-氯噻唑并[5,4-d]嘧啶-2-基)-对甲苯-胺 (7-氯噻唑并[5,4-d]嘧啶-2-基)-吡啶-3-基-胺 (7-氯噻唑并[5,4-d]嘧啶-2-基)-(4-甲氧基苯基)胺 (7-氯噻唑并[5,4-d]嘧啶-2-基)-(2,6-二甲基苯基)胺 (6CI,7CI,8CI,9CI)-噻唑并[5,4-d]嘧啶 4-[7-methyl-4,6-dioxo-2-(3-phenyl-prop-1-ynyl)-6,7-dihydro-4H-1,4l4-dithia-3,5,7-triaza-inden-5-ylmethyl]-benzoic acid 7-Amino-2-methyl-5-hydroxy-thieno<3.2-g>pteridin 7-Amino-3-ethylmercapto-5-hydroxy-2-methyl-thieno<3.2-g>pteridin 2-(6-morpholin-4-yl-4H-[1,3]dithiino[5,4-d]pyrimidin-8-ylamino)-ethanol 2-ethoxycarbonylaminothiazolo[5,4-d]pyrimidine-7(6H)-one 7-chlorothiazolo[5,4-b]pyridine-2-carbonitrile 3-Brom-5-oxo-7-amino-2-(1,2-dihydroxyethyl)-thieno<3.2-g>pteridin 5-amino-2-(cyclohexyl)thiazolo[5,4-d]pyrimidine-7-thiol 5-amino-2-(2-furyl)-thiazolo[5,4-d]pyrimidine-7-thiol